Clinical Trial

To Evaluate the Efficacy and Safety of the Insulin Patch Pump System in Patients With Diabetes.

Completed
View on ClinicalTrials.gov →
Summary
Patients will be enrolled and randomly assigned to either the test group or the control group for short-time intensive insulin therapy in inpatient setting. The test group will receive treatment with the Insulin Patch Pump System, while the control group will be treated with the Medtronic MMT-1805 insulin pump (MiniMed 700). The treatment period will last 7 days, during which blood glucose monitoring will be conducted in both groups.
Trial Details
NCT Number NCT07403565
Lead Sponsor Suzhou Hechun Medical Technology Co., Ltd.
Conditions Type 1 Diabetes, Type 2 Diabetes
Enrollment 161 participants
Start Date 2025-06-14
Primary Completion 2025-11-08 (estimated)
Study Completion 2025-12-03 (estimated)
Updated on ClinicalTrials.gov 2026-02-11